Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 18, 2018 - Issue 12
Submit an article Journal homepage
307
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Wide variation in the use and understanding of therapeutic drug monitoring for anti-TNF agents in inflammatory bowel disease: an inexact science?

Mark A SamaanGuy’s & St. Thomas’ NHS Foundation Trust, IBD Centre, London, UKCorrespondence[email protected]
View further author information
,
Zehra ArkirViapath, Reference Chemistry Laboratory, St Thomas’ Hospital, London, UKView further author information
,
Tariq AhmadRoyal Devon & Exeter NHS Foundation Trust, IBD and Pharmacogenetics Research Group, Exeter, UKView further author information
&
Peter M IrvingGuy’s & St. Thomas’ NHS Foundation Trust, IBD Centre, London, UKView further author information
Pages 1271-1279 | Received 25 Aug 2018, Accepted 15 Oct 2018, Published online: 24 Oct 2018

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Kristin H. Bjørlykke, Jørgen Jahnsen, Jørn Brynskov, Pauliina Molander, Michael Eberhardson, Loà G. Davidsdottir, Taina Sipponen, Henrik Hjortswang, Guro Løvik Goll, Silje Watterdal Syversen, Ebbe Langholz, Kristin K. Jørgensen & Casper Steenholdt. (2023) Therapeutic drug monitoring in inflammatory bowel disease: implementation, utilization, and barriers in clinical practice in Scandinavia. Scandinavian Journal of Gastroenterology 58:1, pages 25-33.
Read now
Katrine Risager Christensen, Casper Steenholdt, Sine Buhl, Jørn Brynskov & Mark Andrew Ainsworth. (2022) A systematic monitoring approach to biologic therapies in inflammatory bowel disease: patients’ and physicians’ preferences and adherence. Scandinavian Journal of Gastroenterology 57:3, pages 274-281.
Read now

Articles from other publishers (10)

Antony Raharja, Zehra Arkir, Giulia Rinaldi, Teresa Tsakok, Tejus Dasandi, Sarah Guard, Arlene McGuire, Andrew E. Pink, Richard Woolf, Jonathan N. Barker, Catherine H. Smith & Satveer K. Mahil. (2023) Real-World Implementation and Outcomes of Adalimumab Therapeutic Drug Monitoring in Psoriasis: A National Specialized Center Experience. Journal of Investigative Dermatology.
Crossref
Paul Firman, Ken-Soon Tan, Alexandra Clavarino, Meng-Wong Taing & Karen Whitfield. (2022) Pharmacist-Managed Therapeutic Drug Monitoring Programs within Australian Hospital and Health Services—A National Survey of Current Practice. Pharmacy 10:5, pages 135.
Crossref
Maria Dorn-RasmussenSine BuhlJørn BrynskovJakob T. BayNils BolstadTobias W. Klausen, David J. WarrenMark A. AinsworthCasper Steenholdt. (2022) Drug Levels Associated With Optimal Discrimination Between Remission and Nonremission and Comparison of Antibody Assays During First Year of Stable Infliximab Maintenance Therapy in Inflammatory Bowel Disease. Therapeutic Drug Monitoring 44:2, pages 290-300.
Crossref
Paulina Nuñez F, Uma Mahadevan, Rodrigo Quera, Constanza Bay & Patricio Ibañez. (2021) Treat-to-target approach in the management of inflammatory Bowel disease. Gastroenterología y Hepatología 44:4, pages 312-319.
Crossref
Paulina Nuñez F, Uma Mahadevan, Rodrigo Quera, Constanza Bay & Patricio Ibañez. (2021) Treat-to-target approach in the management of inflammatory Bowel disease. Gastroenterología y Hepatología (English Edition) 44:4, pages 312-319.
Crossref
Rebecca Sagar, Marco V. Lenti, Tanya Clark, Helen J. Rafferty, David J. Gracie, Alexander C. Ford, Anthony O’Connor, Tariq Ahmad, P. John Hamlin & Christian P. Selinger. (2021) Infliximab Therapeutic Drug Monitoring in Inflammatory Bowel Disease Virtual Biologics Clinic Leads to Durable Clinical Results. Inflammatory Intestinal Diseases 6:3, pages 132-139.
Crossref
Gaurav B Nigam, Shadab Nayeemuddin, Evangelos Kontopantelis, Bu'Hussain Hayee & Jimmy K Limdi. (2021) UK National Survey of Gastroenterologists’ attitudes and barriers toward therapeutic drug monitoring of anti-TNF therapy in inflammatory bowel disease. Frontline Gastroenterology 12:1, pages 22-29.
Crossref
Nina ScheffeRupert SchreinerAnne Thomann & Peter Findeisen. (2020) Development of a Mass Spectrometry-Based Method for Quantification of Ustekinumab in Serum Specimens. Therapeutic Drug Monitoring 42:4, pages 572-577.
Crossref
José Germán Sánchez‐Hernández, Noemí Rebollo, Ana Martin‐Suarez, M. Victoria Calvo & Fernando Muñoz. (2020) A 3‐year prospective study of a multidisciplinary early proactive therapeutic drug monitoring programme of infliximab treatments in inflammatory bowel disease. British Journal of Clinical Pharmacology 86:6, pages 1165-1175.
Crossref
Rajan N. Patel, Gaurav B. Nigam, Raj G. Jatale, Devendra Desai, Govind Makharia, Vineet Ahuja & Jimmy K. Limdi. (2020) An Indian national survey of therapeutic drug monitoring with anti-tumor necrosis (TNF) medications in inflammatory bowel disease. Indian Journal of Gastroenterology 39:2, pages 176-185.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.